Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06486948 · ClinicalTrials.gov registry record · NA
An Exploratory, Double-arm, 8-week Study to Explore the Feasibility and Acceptability of Abbreviated Treatment with CT-156 in People with Schizophrenia.
A NA study, sponsored by Click Therapeutics.
- Completed
- Registry status
- NA
- Development phase
- 58
- Enrollment target
NCT06486948 is a NA study that has completed, run by Click Therapeutics. The registered enrollment target is 58 participants.
The verdict
NCT06486948, a NA study, has completed, sponsored by Click Therapeutics.
- COMPLETED
- Registry status
- NA
- Development phase
- 58 participants
- Enrollment target
Study Summary
An exploratory, double-arm, 8-week study to explore the feasibility and acceptability of abbreviated treatment with CT-156 for people with Schizophrenia.
Interventions
- DEVICE CT-156
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2024-05-06 |
| Est. Completion | 2024-08-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06486948
The ClinicalTrials.gov registry entry for NCT06486948 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 58 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Click Therapeutics, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CT-156 is the first listed.
NCT06486948 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06486948 about?
NCT06486948 is a clinical study titled "An Exploratory, Double-arm, 8-week Study to Explore the Feasibility and Acceptability of Abbreviated Treatment with CT-156 in People with Schizophrenia.". An exploratory, double-arm, 8-week study to explore the feasibility and acceptability of abbreviated treatment with CT-156 for people with Schizophrenia.
What is the current status of trial NCT06486948?
This trial is currently completed. It is a NA study. The enrollment target is 58 participants. The study started on 2024-05-06. Estimated completion is 2024-08-09.
What interventions are being tested in trial NCT06486948?
The interventions under investigation include: CT-156 (DEVICE).
Who is sponsoring clinical trial NCT06486948?
This trial is sponsored by Click Therapeutics, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.